Skip to main content
Quest Diagnostics

Insulin Resistance (IR) and BMI in a Multiethnic Population of Normoglycemic Adults

ENDO 2025

American Society for Microbiology

San Francisco, CA, July 12-15, 2025

Poster presentation: Insulin Resistance (IR) and BMI in a Multiethnic Population of Normoglycemic Adults

Authors: Louie JZ, Shiffma D, Meigs JB, McPhaul MJ

Medical Specialty: Cardiovascular disease, Endocrinology, Cardiology

Related content

Audio Podcast
Action From Insight: Tackling Insulin Resistance
Audio Podcast
The Insulin Resistance Revolution: The Key to Preventing Chronic Conditions
Test FAQ
CardioIQ® Insulin Resistance Panel with Score
Conference Presentation
Among Those With Normoglycemia, Insulin Resistance Risk Score (IRRS) Elevation is Observed up to 3 Years Prior to Diagnosis of Diabetes or Prediabetes
Conference Presentation
Measures of Insulin Resistance (IR) Increase with Increasing BMI in a Population of Normoglycemic Working Adults
On-Demand Webinar
Early identification of cardiometabolic disease: NAFLD/MASLD & NASH/MASH
Publication
An Insulin Resistance Score Improved Diabetes Risk Assessment in the Malmö Prevention Project-A Longitudinal Population-Based Study of Older European

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.